Last update 21 Nov 2024
AML1-ETO neoantigen cytotoxic T cells(BGI Shenzhen)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type T-lymphocyte cell therapy |
Synonyms AML1-ETO CTL(BGI Shenzhen) |
Target |
Mechanism AML1-ETO modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with AML1-ETO neoantigen cytotoxic T cells(BGI Shenzhen)A Clinical Study to Evaluate the Safety and Initial Efficacy of Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL) in the Treatment of Relapsed or Refractory t(8; 21) AML
100 Clinical Results associated with AML1-ETO neoantigen cytotoxic T cells(BGI Shenzhen)
Login to view more data
100 Translational Medicine associated with AML1-ETO neoantigen cytotoxic T cells(BGI Shenzhen)
Login to view more data
100 Patents (Medical) associated with AML1-ETO neoantigen cytotoxic T cells(BGI Shenzhen)
Login to view more data
100 Deals associated with AML1-ETO neoantigen cytotoxic T cells(BGI Shenzhen)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Refractory acute myeloid leukemia | Phase 1 | CN | 01 Feb 2024 | |
| Relapsing acute myeloid leukemia | Phase 1 | CN | 01 Feb 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free